Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 24403561)

1.

Human classical monocytes control the intracellular stage of Leishmania braziliensis by reactive oxygen species.

Novais FO, Nguyen BT, Beiting DP, Carvalho LP, Glennie ND, Passos S, Carvalho EM, Scott P.

J Infect Dis. 2014 Apr 15;209(8):1288-96. doi: 10.1093/infdis/jiu013. Epub 2014 Jan 7.

2.

CXCL10 production by human monocytes in response to Leishmania braziliensis infection.

Vargas-Inchaustegui DA, Hogg AE, Tulliano G, Llanos-Cuentas A, Arevalo J, Endsley JJ, Soong L.

Infect Immun. 2010 Jan;78(1):301-8. doi: 10.1128/IAI.00959-09. Epub 2009 Nov 9.

3.

Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World.

Salay G, Dorta ML, Santos NM, Mortara RA, Brodskyn C, Oliveira CI, Barbiéri CL, Rodrigues MM.

Clin Vaccine Immunol. 2007 Sep;14(9):1173-81. Epub 2007 Jul 11.

4.

Resistance of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis to nitric oxide correlates with disease severity in Tegumentary Leishmaniasis.

Giudice A, Camada I, Leopoldo PT, Pereira JM, Riley LW, Wilson ME, Ho JL, de Jesus AR, Carvalho EM, Almeida RP.

BMC Infect Dis. 2007 Feb 22;7:7.

5.

Comparative expression profiling of Leishmania: modulation in gene expression between species and in different host genetic backgrounds.

Depledge DP, Evans KJ, Ivens AC, Aziz N, Maroof A, Kaye PM, Smith DF.

PLoS Negl Trop Dis. 2009 Jul 7;3(7):e476. doi: 10.1371/journal.pntd.0000476.

6.

S-nitrosoglutathione (GSNO) is cytotoxic to intracellular amastigotes and promotes healing of topically treated Leishmania major or Leishmania braziliensis skin lesions.

Costa IS, de Souza GF, de Oliveira MG, Abrahamsohn Ide A.

J Antimicrob Chemother. 2013 Nov;68(11):2561-8. doi: 10.1093/jac/dkt210. Epub 2013 Jun 19.

7.

Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice.

Rocha FJ, Schleicher U, Mattner J, Alber G, Bogdan C.

Infect Immun. 2007 Aug;75(8):3823-32. Epub 2007 May 21.

8.

Morita-Baylis-Hillman adduct shows in vitro activity against Leishmania (Viannia) braziliensis associated with a reduction in IL-6 and IL-10 but independent of nitric oxide.

Amorim FM, Rodrigues YK, Barbosa TP, Néris PL, Caldas JP, Sousa SC, Leite JA, Rodrigues-Mascarenhas S, Vasconcellos ML, Oliveira MR.

Parasitology. 2013 Jan;140(1):29-38. doi: 10.1017/S0031182012001291. Epub 2012 Aug 20.

PMID:
22906971
9.

Macrophages participate in host protection and the disease pathology associated with Leishmania braziliensis infection.

Giudice A, Vendrame C, Bezerra C, Carvalho LP, Delavechia T, Carvalho EM, Bacellar O.

BMC Infect Dis. 2012 Mar 29;12:75. doi: 10.1186/1471-2334-12-75.

10.
11.

Resistance of Leishmania (Viannia) braziliensis to nitric oxide: correlation with antimony therapy and TNF-alpha production.

Souza AS, Giudice A, Pereira JM, Guimarães LH, de Jesus AR, de Moura TR, Wilson ME, Carvalho EM, Almeida RP.

BMC Infect Dis. 2010 Jul 15;10:209. doi: 10.1186/1471-2334-10-209.

12.

Leishmanicidal activity of synthetic chalcones in Leishmania (Viannia) braziliensis.

de Mello TF, Bitencourt HR, Pedroso RB, Aristides SM, Lonardoni MV, Silveira TG.

Exp Parasitol. 2014 Jan;136:27-34. doi: 10.1016/j.exppara.2013.11.003. Epub 2013 Nov 21.

PMID:
24269198
13.

Immunoregulatory profile of monocytes from cutaneous leishmaniasis patients and association with lesion size.

Vieira ÉL, Keesen TS, Machado PR, Guimarães LH, Carvalho EM, Dutra WO, Gollob KJ.

Parasite Immunol. 2013 Feb;35(2):65-72. doi: 10.1111/pim.12012.

14.

Biogenesis of Leishmania-harbouring parasitophorous vacuoles following phagocytosis of the metacyclic promastigote or amastigote stages of the parasites.

Courret N, Fréhel C, Gouhier N, Pouchelet M, Prina E, Roux P, Antoine JC.

J Cell Sci. 2002 Jun 1;115(Pt 11):2303-16.

16.

BALB/c mice infected with antimony treatment refractory isolate of Leishmania braziliensis present severe lesions due to IL-4 production.

Costa DL, Carregaro V, Lima-Júnior DS, Silva NM, Milanezi CM, Cardoso CR, Giudice Â, de Jesus AR, Carvalho EM, Almeida RP, Silva JS.

PLoS Negl Trop Dis. 2011 Mar 1;5(3):e965. doi: 10.1371/journal.pntd.0000965.

17.

Infection of human monocytes by Leishmania results in a defective oxidative burst.

Passwell JH, Shor R, Smolen J, Jaffe CL.

Int J Exp Pathol. 1994 Aug;75(4):277-84.

18.

Leishmania eukaryotic initiation factor (LeIF) inhibits parasite growth in murine macrophages.

Koutsoni O, Barhoumi M, Guizani I, Dotsika E.

PLoS One. 2014 May 15;9(5):e97319. doi: 10.1371/journal.pone.0097319. eCollection 2014.

19.

Enhanced Leishmania braziliensis infection following pre-exposure to sandfly saliva.

de Moura TR, Oliveira F, Novais FO, Miranda JC, Clarêncio J, Follador I, Carvalho EM, Valenzuela JG, Barral-Netto M, Barral A, Brodskyn C, de Oliveira CI.

PLoS Negl Trop Dis. 2007 Nov 28;1(2):e84.

20.

Functional transcriptomics of wild-caught Lutzomyia intermedia salivary glands: identification of a protective salivary protein against Leishmania braziliensis infection.

de Moura TR, Oliveira F, Carneiro MW, Miranda JC, Clarêncio J, Barral-Netto M, Brodskyn C, Barral A, Ribeiro JM, Valenzuela JG, de Oliveira CI.

PLoS Negl Trop Dis. 2013 May 23;7(5):e2242. doi: 10.1371/journal.pntd.0002242. Print 2013.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk